Philips launches Rapid Equipment Deployment Kit to COVID-19 response
August 13 2020 - 09:00AM
August 13, 2020
- New initiative can provide critical care patient monitoring
anywhere, anytime to help meet the urgent challenges of ICU
capacity
- Helps mitigate the impact of natural disasters and pandemics
like the ongoing COVID-19 outbreak
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG,
AEX: PHIA), a global leader in health technology, today introduced
its Rapid Equipment Deployment Kit for ICU ramp-ups, allowing
doctors, nurses, technicians and hospital staff to quickly support
critical care patient monitoring capabilities during the COVID-19
pandemic. Currently successfully in use in the first health
systems across the US [1], the Rapid Equipment Deployment Kit
combines Philips advanced patient monitoring technology with
predictive patient centric algorithms enabling care teams to
quickly scale up critical care patient monitoring capabilities
within a few hours [2]. As health systems in the U.S.
continue to experience surges in critical care and emergency care
demand related to the COVID-19 crisis, the kit provides hospitals a
way to quickly and easily expand their critical care capacity.
Innovative approach to help manage capacity surge in the
ICUThe Philips Rapid Equipment Deployment Kit is a fully
configured and ready-to-deploy ICU patient monitoring solution,
which includes 20 ICU monitors, 20 measurement servers and one
central management monitoring station. The kits are pre-built,
pre-configured and pre-packed into sturdy cases that can elevate a
hospital’s general care area to a critical care level in a matter
of hours [3]. Kits are complete with step-by-step instructions
allowing the pre-configured system to be deployed by hospital
staff, with remote technical and clinical support from Philips.
Kits can be transferred from hospital to hospital as needed. Once a
crisis/surge passes, the kits are disinfected, packed up and stored
to have available in preparation for future emergencies.
“The current health crisis has demonstrated a clear need for us
to deliver innovative solutions to our customers that provide a
complete critical care monitoring solution with all of the
equipment they require on demand. This eliminates the need to
source and configure individual pieces of high-demand equipment
during a crisis,” said Peter Ziese, General Manager of Monitoring
Analytics at Philips. “To help ensure economical and more
efficient use of hospital resources, the Rapid Equipment Deployment
Kits provide the speed, flexibility and ease of implementation for
advanced critical care patient monitoring that many of our
customers must have during this most pressing time.”
Philips critical care patient monitoring solutionsIn
June, Philips announced it had received Emergency Use Authorization
from the FDA for Philips’ IntelliVue Patient Monitors MX750/MX850
and its IntelliVue Active Displays AD75/AD85, for use in the US
during the COVID-19 health emergency [4]. These patient monitoring
solutions support infection-control protocols and remotely provide
critical patient information when caring for hospitalized COVID-19
patients. The MX750 and MX850 monitors are the latest
additions to Philips’ portfolio of integrated patient monitoring
solutions to help support improved clinical and operational
workflows. Updated features, include enhancements to monitor and
assess clinical and network device performance, and additional
functionalities to strengthen cybersecurity. Visit Philips critical
care patient monitoring for more information on the Rapid Equipment
Deployment Kits in the US market and Philips full suite of critical
care patient monitoring solutions.
Philips COVID-19 solutions portfolioPhilips has a
comprehensive portfolio of services and solutions to help support
the delivery of high-quality care to COVID-19 patients. Solutions
include secure, connected and intelligent approaches to diagnosis,
treatment and predictive monitoring in the hospital, plus
screening, remote patient monitoring and care at home. With
healthcare under more pressure than ever before, Philips’
telehealth and AI-enabled data analytics can help support
workflows, facilitate remote collaboration and optimize resources.
Philips’ COVID-19-related solutions are designed for rapid
deployment and scalability. For more information on how Philips is
addressing COVID-19 globally, please visit the Philips
centralized COVID-19 hub.
[1] Philips Rapid Equipment Deployment Kits are available in the
US market only.Kits are available in the US market only.[2]
Compared to Philips' standard delivery time of 12-16 weeks. Average
time for delivery is 7 days as of July 2020.[3] Compared to
Philips' standard go-live of 5-7 days upon arrival. Average time
for go-live is 5 hours as of July 2020.4] The status of the
Emergency Use Authorization can be found on the FDA website.
- The IntelliVue Patient Monitors MX750/MX850, IntelliVue 4-Slot
Module Rack FMX-4 and IntelliVue Active Displays AD75/AD85 have
neither been FDA cleared or approved for the indication to assist
in for monitoring and recording of, and for generating alarms for,
multiple physiological parameters of adult, pediatric, and neonate
patients having or suspected of having Coronavirus-2019
(COVID-19)
- The IntelliVue Patient Monitors MX750/MX850, IntelliVue 4-Slot
Module Rack FMX-4 and IntelliVue Active Displays AD75/AD85 have
been authorized for the emergency use by FDA under an EUA
- The IntelliVue Patient Monitors MX750/MX850, IntelliVue 4-Slot
Module Rack FMX-4 and IntelliVue Active Displays AD75/AD85 have
been authorized only for the duration of the declaration that
circumstances exist justifying the authorization of the emergency
use of medical devices under section 564(b)(1) of the Act, 21
U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or
revoked sooner.
For further information, please contact:
Kathy O’ReillyPhilips Global Press OfficeTel.: +1
978-221-8919E-Mail: kathy.oreilly@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
enabling better outcomes across the health continuum from healthy
living and prevention, to diagnosis, treatment and home care.
Philips leverages advanced technology and deep clinical and
consumer insights to deliver integrated solutions. Headquartered in
the Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health informatics, as
well as in consumer health and home care. Philips generated 2019
sales of EUR 19.5 billion and employs approximately 81,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
- Critical Care Anywhere
- Philips REDI Kit
- Manage ICU Surge
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From Feb 2024 to Mar 2024
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From Mar 2023 to Mar 2024